MENU
+Compare
CVAC
Stock ticker: NASDAQ
AS OF
Jun 12 closing price
Price
$5.60
Change
+$1.53 (+37.59%)
Capitalization
916.4M

CVAC CureVac NV Forecast, Technical & Fundamental Analysis

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people... Show more

CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CVAC with price predictions
Jun 12, 2025

CVAC's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CVAC turned positive on June 12, 2025. Looking at past instances where CVAC's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where CVAC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 12, 2025. You may want to consider a long position or call options on CVAC as a result. In of 72 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CVAC advanced for three days, in of 242 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 81 cases where CVAC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVAC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CVAC broke above its upper Bollinger Band on June 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.705) is normal, around the industry mean (16.792). P/E Ratio (6.121) is within average values for comparable stocks, (59.920). CVAC's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.337). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (2.108) is also within normal values, averaging (258.227).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CVAC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CVAC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CVAC is expected to report earnings to fall 80.04% to -4 cents per share on August 14

CureVac NV CVAC Stock Earnings Reports
Q2'25
Est.
$-0.05
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.09
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.04
The last earnings report on May 20 showed earnings per share of -23 cents, missing the estimate of -16 cents. With 22.95M shares outstanding, the current market capitalization sits at 916.40M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company developing tumour immunotherapy

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Friedrich-Miescher-Strasse 15
Phone
+49 707198830
Employees
1049
Web
https://www.curevac.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFANX13.43N/A
N/A
Fidelity Asset Manager 40%
EMACX13.47N/A
N/A
Gabelli Entpr Mergers & Acquisitions C
JAMCX34.82N/A
N/A
JPMorgan Mid Cap Value A
WIEMX2.87N/A
N/A
Wasatch Emerging Markets Small Cap Instl
TGRHX7.28N/A
N/A
Transamerica International Focus A

CVAC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with MDGL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
+37.59%
MDGL - CVAC
42%
Loosely correlated
+0.98%
MRNA - CVAC
41%
Loosely correlated
-1.44%
ARCT - CVAC
41%
Loosely correlated
+1.61%
BNTX - CVAC
40%
Loosely correlated
-0.51%
IMNM - CVAC
39%
Loosely correlated
+3.16%
More